UPDATE: Oppenheimer Downgrades Mirati Therapeutics (MRTX) to Perform
Tweet Send to a Friend
(Updated - May 17, 2021 6:06 AM EDT)
Oppenheimer analyst Jay Olson downgraded Mirati Therapeutics (NASDAQ: MRTX) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jay Olson downgraded Mirati Therapeutics (NASDAQ: MRTX) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
